Form 4: Nuvalent Executive Receives Stock Grant
Insider Transaction (Form 4)
Christopher Durant Turner, Chief Medical Officer of Nuvalent, Inc., reported multiple transactions in common stock on July 15, 2026.
Summary
- Tender of shares: disposed of 31,530 Class A Common Stock at $124.00 ($3,909,720) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 41,100 Class A Common Stock - Restricted Stock Units on July 15, 2026 (Direct).
- Grant/award: acquired 14,350 Class A Common Stock - Performance Stock Units on July 15, 2026; holds 14,350 after (Direct).
- Disposition to the issuer: disposed of 14,350 Class A Common Stock - Performance Stock Units on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 303,105 Stock Option (Right to Buy) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 2,835 Stock Option (Right to Buy) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 107,000 Stock Option (Right to Buy) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 144,200 Stock Option (Right to Buy) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 47,500 Stock Option (Right to Buy) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 37,500 Stock Option (Right to Buy) on July 15, 2026 (Direct).
- Disposition to the issuer: disposed of 17,500 Stock Option (Right to Buy) on July 15, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Christopher Durant Turner — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Tender of shares | Class A Common Stock | 31,530 | $124 | $3.9M | 0 |
| 2026-07-15 | Disposition to the issuer | Class A Common Stock - Restricted Stock Units | 41,100 | — | — | 0 |
| 2026-07-15 | Grant/award | Class A Common Stock - Performance Stock Units | 14,350 | — | — | 14,350 |
| 2026-07-15 | Disposition to the issuer | Class A Common Stock - Performance Stock Units | 14,350 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 303,105 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 2,835 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 107,000 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 144,200 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 47,500 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 37,500 | — | — | 0 |
| 2026-07-15 | Disposition to the issuer | Stock Option (Right to Buy) | 17,500 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Tender of shares (31,530 shares) |
| 2026-07-15 | Disposition to the issuer (41,100 shares) |
| 2026-07-15 | Grant/award (14,350 shares) |
| 2026-07-15 | Disposition to the issuer (14,350 shares) |
| 2026-07-15 | Disposition to the issuer (303,105 shares) |
| 2026-07-15 | Disposition to the issuer (2,835 shares) |
| 2026-07-15 | Disposition to the issuer (107,000 shares) |
| 2026-07-15 | Disposition to the issuer (144,200 shares) |
| 2026-07-15 | Disposition to the issuer (47,500 shares) |
| 2026-07-15 | Disposition to the issuer (37,500 shares) |
| 2026-07-15 | Disposition to the issuer (17,500 shares) |
Keywords
insider transaction, Form 4, NUVL, Nuvalent, Inc., neutral, Christopher Durant Turner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.